In focus · trending topic

VBI Vaccines

8 stories · following the connections

VBI Vaccines Announces First Quarter 2018 Financial Results and Provides Corporate Update

By Nasdaq OMXMay 1, 2018, 12:01 PM UTC

VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study for Sci-B-Vac® Hepatitis B Vaccine

By Nasdaq OMXApr 19, 2018, 12:00 PM UTC

VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients

By Nasdaq OMXApr 17, 2018, 12:01 PM UTC

VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange

By Nasdaq OMXMar 12, 2018, 8:15 PM UTC

VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901

By Nasdaq OMXJan 17, 2018, 1:00 PM UTC

VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

By Nasdaq OMXDec 12, 2017, 1:00 PM UTC

VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum

By Nasdaq OMXNov 2, 2017, 12:02 PM UTC

VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares

By Nasdaq OMXOct 31, 2017, 12:31 PM UTC